Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC.AIG · Entity 3083 | EVP and Chief HR Officer | March 30, 2021 | April 01, 2021 |
| Allergan plcAGN · Entity 149298 | EVP & Chief H.R. Officer | April 03, 2019 | April 05, 2019 |
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | May 26, 2026 | May 28, 2026 |
| TherapeuticsMD, Inc.TXMD · Entity 7541 | Director | September 29, 2022 | October 03, 2022 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | Director | May 27, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN INTERNATIONAL GROUP, INC.
Report date March 30, 2021 · Filed April 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| 2020 Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,210 |
Reported balance
After 2021-03-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-03-30 · Grant · Acquired 89 · Balance 13,210 F1: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 4,697 |
Reported balance
After 2021-03-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-03-30 · Grant · Acquired 32 · Balance 4,697 F2: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis.
F2: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis.
Allergan plc
Report date April 03, 2019 · Filed April 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value $0.0001SEC Table I · non-derivative | Direct | 25,132.095 |
Reported balance
After 2019-04-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-04-03 · Tax withholding · Disposed 394 · Balance 25,132.095 F1: Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
Bausch & Lomb Corp
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 61,518 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 15,842 · Balance 61,518 F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.
TherapeuticsMD, Inc.
Report date September 29, 2022 · Filed October 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 5,000 |
Reported balance
After 2022-09-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-09-29 · Grant · Acquired 5,000 · Balance 5,000 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. The RSU's will vest on September 29, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. The RSU's will vest on September 29, 2023.
iRhythm Holdings, Inc.
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,141 |
Reported balance
After 2026-05-27 transaction · row 1
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 1,573 · Balance 11,141 F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Keenova Therapeutics plc
Report date November 14, 2023 · Filed November 16, 2023
Section 16 reporting ended · disclosed 2023-11-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-11-14 transaction · row 1
1 source rowRow 1 · 2023-11-14 · Disposition to issuer · Disposed 23,122 · Balance 0 F1: On August 28, 2023, Mallinckrodt plc (the "Company") and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"). On September 20, 2023, the Company's directors presented a petition before the High Court of Ireland (the "Irish High Court") seeking the appointment of an examiner (the "Examiner") to the Company, thereby commencing examinership proceedings with respect to the Company in Ireland. F2: On October 10, 2023, the Bankruptcy Court entered an order confirming the First Amended Prepackaged Joint Chapter 11 Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates (as may be amended or supplemented from time to time in accordance with its terms, the "Plan"). On November 10, 2023, the Irish High Court made an order confirming a scheme of arrangement proposed by the Examiner that is based on and consistent in all respects with the Plan (the "Scheme"). On November 14, 2023 (the "Effective Date"), the Plan and the Scheme became effective and the Company emerged from bankruptcy. F3: On the Effective Date, all of the Company's previously outstanding ordinary shares (the "Ordinary Shares"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such Ordinary Shares, were cancelled and extinguished pursuant to the Plan and the Scheme. In connection with emergence, the reporting person ceased to be a Section 16 reporting person. This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 28, 2023, Mallinckrodt plc (the "Company") and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"). On September 20, 2023, the Company's directors presented a petition before the High Court of Ireland (the "Irish High Court") seeking the appointment of an examiner (the "Examiner") to the Company, thereby commencing examinership proceedings with respect to the Company in Ireland.
F2: On October 10, 2023, the Bankruptcy Court entered an order confirming the First Amended Prepackaged Joint Chapter 11 Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates (as may be amended or supplemented from time to time in accordance with its terms, the "Plan"). On November 10, 2023, the Irish High Court made an order confirming a scheme of arrangement proposed by the Examiner that is based on and consistent in all respects with the Plan (the "Scheme"). On November 14, 2023 (the "Effective Date"), the Plan and the Scheme became effective and the Company emerged from bankruptcy.
F3: On the Effective Date, all of the Company's previously outstanding ordinary shares (the "Ordinary Shares"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such Ordinary Shares, were cancelled and extinguished pursuant to the Plan and the Scheme. In connection with emergence, the reporting person ceased to be a Section 16 reporting person. This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2026 Filed May 29, 2026 20:04 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 1,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001597450-26-000003 · wk-form4_1780085051.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,141 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. Read SEC document |
| May 26, 2026 Filed May 28, 2026 21:05 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 15,842 | $15.78 | $249,986.76 |
DisclosureSEC source: 0001860742-26-000078 · form4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,518 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:20 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000020 · form4.xml · nonDerivative · entry 2 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,676 F2 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances). Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:20 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | PurchaseCommon Shares, No Par Value | 4,000 | $17.74 | $70,968.00 |
DisclosureSEC source: 0001860742-26-000020 · form4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,676 F1 · price: Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.71 to $17.75 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 28, 2025 Filed May 29, 2025 20:02 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 1,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-25-000129 · wk-form4_1748548958.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,568 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:07 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015803 · form4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,676 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 21:56 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021757 · form4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,338 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 29, 2024 Filed Jun 3, 2024 22:48 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-24-000122 · wk-form4_1717454928.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,210 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:09 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 2,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009005 · form4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,642 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 21:12 UTC | Keenova Therapeutics plc MNKTQ · Entity 28960 | Disposition to issuerOrdinary Shares | 23,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-119109 · tm2330745-9_4seq1.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On August 28, 2023, Mallinckrodt plc (the "Company") and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"). On September 20, 2023, the Company's directors presented a petition before the High Court of Ireland (the "Irish High Court") seeking the appointment of an examiner (the "Examiner") to the Company, thereby commencing examinership proceedings with respect to the Company in Ireland. F2 · kind: On October 10, 2023, the Bankruptcy Court entered an order confirming the First Amended Prepackaged Joint Chapter 11 Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates (as may be amended or supplemented from time to time in accordance with its terms, the "Plan"). On November 10, 2023, the Irish High Court made an order confirming a scheme of arrangement proposed by the Examiner that is based on and consistent in all respects with the Plan (the "Scheme"). On November 14, 2023 (the "Effective Date"), the Plan and the Scheme became effective and the Company emerged from bankruptcy. F3 · kind: On the Effective Date, all of the Company's previously outstanding ordinary shares (the "Ordinary Shares"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such Ordinary Shares, were cancelled and extinguished pursuant to the Plan and the Scheme. In connection with emergence, the reporting person ceased to be a Section 16 reporting person. This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014. Read SEC document |
| June 16, 2023 Filed Jun 29, 2023 22:51 UTC | Keenova Therapeutics plc MNK · Entity 28960 | Disposition to issuerOrdinary Shares | 26,277 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-076469 · tm2320181d6_4seq1.xml · nonDerivative · entry 2 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,122 F1 · shares: The restricted stock units (the "RSUs") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc ("Mallinckrodt") in connection with the Board of Directors (the "Board") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the "Compensation Changes"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $210,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $245,000. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023. F1 · price: The restricted stock units (the "RSUs") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc ("Mallinckrodt") in connection with the Board of Directors (the "Board") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the "Compensation Changes"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $210,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $245,000. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023. F1 · balance_after: The restricted stock units (the "RSUs") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc ("Mallinckrodt") in connection with the Board of Directors (the "Board") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the "Compensation Changes"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $210,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $245,000. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023. Read SEC document |
| June 16, 2023 Filed Jun 29, 2023 22:51 UTC | Keenova Therapeutics plc MNK · Entity 28960 | Tax withholdingOrdinary Shares | 3,154 | $1.28 | $4,037.12 |
DisclosureSEC source: 0001104659-23-076469 · tm2320181d6_4seq1.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,399 Read SEC document |
| May 24, 2023 Filed May 25, 2023 18:08 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 1,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-23-000054 · wk-form4_1685038122.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,137 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The RSUs fully vest on May 24, 2024. Read SEC document |
| May 24, 2023 Filed Aug 16, 2023 20:18 UTC Amendment | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 1,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-23-000128 · wk-form4a_1692217083.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,369 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The RSUs fully vest on May 24, 2024. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 23:01 UTC | Keenova Therapeutics plc MNK · Entity 28960 | GrantOrdinary Shares | 26,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001542 · tm231710-4_4seq1.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,553 F1 · shares: The reported ordinary shares represent restricted stock units ("RSUs"), which will be settled in an equal number of MNK ordinary shares and will vest ratably on each of the first two anniversaries of MNK's emergence from Chapter 11 proceedings on June 16, 2022. F2 · balance_after: The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 26,277 newly awarded RSUs and 26,276 RSUs previously reported in Table II. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 22:38 UTC | TherapeuticsMD, Inc. TXMD · Entity 7541 | GrantRestricted Stock Units · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051957 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. The RSU's will vest on September 29, 2023. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. The RSU's will vest on September 29, 2023. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 01:19 UTC | Keenova Therapeutics plc MNKPF · Entity 28960 | GrantRestricted Stock Units · Derivative | 26,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-100154 · tm2225913-7_4seq1.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,276 Underlying: Ordinary Shares · 26,276 shares Expires not disclosed F1 · derivative.exercise_price: On October 14, 2022, Karen Ling received a grant of 26,276 restricted stock units ("RSUs"), which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt plc's emergence from Chapter 11 proceedings on June 16, 2022. F1 · derivative.exercise_date: On October 14, 2022, Karen Ling received a grant of 26,276 restricted stock units ("RSUs"), which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt plc's emergence from Chapter 11 proceedings on June 16, 2022. F1 · derivative.expiration_date: On October 14, 2022, Karen Ling received a grant of 26,276 restricted stock units ("RSUs"), which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt plc's emergence from Chapter 11 proceedings on June 16, 2022. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 01:49 UTC Amendment | Keenova Therapeutics plc MNKPF · Entity 28960 | GrantRestricted Stock Units · Derivative | 26,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-100536 · tm2225913-8_4aseq1.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,276 Underlying: Ordinary Shares · 26,276 shares Expires not disclosed F1 · derivative.exercise_price: On September 14, 2022, Karen Ling received a grant of 26,276 restricted stock units ("RSUs"), which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt plc's emergence from Chapter 11 proceedings on June 16, 2022. F1 · derivative.exercise_date: On September 14, 2022, Karen Ling received a grant of 26,276 restricted stock units ("RSUs"), which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt plc's emergence from Chapter 11 proceedings on June 16, 2022. F1 · derivative.expiration_date: On September 14, 2022, Karen Ling received a grant of 26,276 restricted stock units ("RSUs"), which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt plc's emergence from Chapter 11 proceedings on June 16, 2022. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 10:00 UTC | TherapeuticsMD, Inc. TXMD · Entity 7541 | Exercise / conversionRestricted Stock Units · Derivative | 1,984 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046965 · doc4.xml · derivative · entry 2 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,984 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022. F2 · shares: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. F3 · derivative.exercise_date: The RSUs vested on July 1, 2022. F3 · derivative.expiration_date: The RSUs vested on July 1, 2022. F1 · derivative.underlying_shares: On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022. F2 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 10:00 UTC | TherapeuticsMD, Inc. TXMD · Entity 7541 | Exercise / conversionCommon Stock | 1,984 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-046965 · doc4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022. Read SEC document |
| May 26, 2022 Filed May 31, 2022 18:57 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 653 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-22-000072 · wf-form4_165402343502574.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,973 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The RSUs fully vest on May 26, 2023 Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 15:45 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 4,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-21-000147 · wf-form4_163604073978317.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,320 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-third of the RSUs vest on November 1, 2022 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:31 UTC | TherapeuticsMD, Inc. TXMD · Entity 7541 | PurchaseCommon Stock | 33,445 | $0.75 | $25,083.75 |
DisclosureSEC source: 0001387131-21-008750 · ownership.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,309 F1 · price: The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.746 to $0.748 for an average weighted purchase price of $0.75. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2021 Filed Aug 13, 2021 01:25 UTC | TherapeuticsMD, Inc. TXMD · Entity 7541 | Exercise / conversionRestricted Stock Units · Derivative | 96,864 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001387131-21-008433 · ownership.xml · derivative · entry 2 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,864 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021. F2 · shares: Each RSU represented a contingent right to receive one share of issuer common stock upon settlement. F3 · derivative.exercise_date: The RSUs vested on June 18, 2021. F3 · derivative.expiration_date: The RSUs vested on June 18, 2021. F1 · derivative.underlying_shares: On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021. F2 · derivative.underlying_shares: Each RSU represented a contingent right to receive one share of issuer common stock upon settlement. Read SEC document |
| August 10, 2021 Filed Aug 13, 2021 01:25 UTC | TherapeuticsMD, Inc. TXMD · Entity 7541 | Exercise / conversionCommon Stock | 96,864 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-21-008433 · ownership.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 22:14 UTC | TherapeuticsMD, Inc. TXMD · Entity 7541 | GrantRestricted Stock Units · Derivative | 99,174 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001387131-21-007139 · ownership.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,174 Underlying: Common Stock · 99,174 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 20:19 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | GrantRestricted Stock Unit · Derivative | 32 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-006200 · doc4.xml · derivative · entry 2 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,697 Underlying: Common Stock · 32 shares Expires not disclosed F2 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 20:19 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Grant2020 Restricted Stock Units · Derivative | 89 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-006200 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,210 Underlying: Common Stock · 89 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · shares: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:22 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Grant2021 Stock Options (Right to Buy) · Derivative | 40,598 | $0.00 Strike: $44.10 | $0.00 |
DisclosureSEC source: 0001225208-21-003620 · doc4.xml · derivative · entry 2 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,598 Underlying: Common Stock · 40,598 shares Expires 2031-02-22 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:22 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Grant2021 Restricted Stock Units · Derivative | 11,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003620 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,229 Underlying: Common Stock · 11,229 shares Expires not disclosed F1 · derivative.exercise_price: The 2021 Restricted Stock Units convert to AIG Common Stock on a 1-to-1 basis. F2 · shares: Represents the grant of 2021 Restricted Stock Units. The 2021 Restricted Stock Units vest on January 1, 2024, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional 2021 Restricted Stock Units. F2 · derivative.exercise_date: Represents the grant of 2021 Restricted Stock Units. The 2021 Restricted Stock Units vest on January 1, 2024, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional 2021 Restricted Stock Units. F2 · derivative.expiration_date: Represents the grant of 2021 Restricted Stock Units. The 2021 Restricted Stock Units vest on January 1, 2024, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional 2021 Restricted Stock Units. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:18 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | GrantRestricted Stock Unit · Derivative | 38 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-20-015126 · doc4.xml · derivative · entry 2 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 Underlying: Common Stock · 38 shares Expires not disclosed F2 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 21:18 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Grant2020 Restricted Stock Units · Derivative | 109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-20-015126 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,121 Underlying: Common Stock · 109 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · shares: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:18 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | GrantRestricted Stock Unit · Derivative | 51 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-20-012046 · doc4.xml · derivative · entry 2 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,627 Underlying: Common Stock · 51 shares Expires not disclosed F2 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded, but not yet vested, under the American International Group, Inc. 2013 Omnibus Incentive Plan on July 29, 2019. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:18 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Grant2020 Restricted Stock Units · Derivative | 144 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-20-012046 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,012 Underlying: Common Stock · 144 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · shares: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 22:45 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Exercise / conversionRestricted Stock Unit · Derivative | 4,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-010071 · doc4.xml · derivative · entry 3 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,576 Underlying: Common Stock · 4,576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The securities convert to AIG Common Stock on a 1-to-1 basis. F1 · shares: Represents AIG Common Stock underlying Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 that vested on July 29, 2020. The remaining Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the applicable vesting date, and are settled in shares of AIG Common Stock. F1 · derivative.exercise_date: Represents AIG Common Stock underlying Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 that vested on July 29, 2020. The remaining Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the applicable vesting date, and are settled in shares of AIG Common Stock. F1 · derivative.expiration_date: Represents AIG Common Stock underlying Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 that vested on July 29, 2020. The remaining Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the applicable vesting date, and are settled in shares of AIG Common Stock. Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 22:45 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Tax withholdingCommon Stock | 2,436 | $32.67 | $79,584.12 |
DisclosureSEC source: 0001225208-20-010071 · doc4.xml · nonDerivative · entry 2 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,373 F2 · shares: Represents shares withheld for the payment of taxes in connection with the settlement in AIG Common Stock of the Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) that vested on July 29, 2020. F3 · price: The number of shares withheld for taxes was determined based on AIG's closing share price on July 29, 2020. Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 22:45 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Exercise / conversionCommon Stock | 4,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-010071 · doc4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents AIG Common Stock underlying Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 that vested on July 29, 2020. The remaining Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest on July 29, 2021, subject to the reporting person's continued employment through the applicable vesting date, and are settled in shares of AIG Common Stock. Read SEC document |
| June 29, 2020 Filed Jul 2, 2020 01:02 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | GrantRestricted Stock Unit · Derivative | 88 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-079993 · tm2023983d6_4.xml · derivative · entry 2 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,152 Underlying: Common Stock · 88 shares Expires not disclosed F2 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| June 29, 2020 Filed Jul 2, 2020 01:02 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Grant2020 Restricted Stock Units · Derivative | 122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-079993 · tm2023983d6_4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,868 Underlying: Common Stock · 122 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · shares: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 21:08 UTC | TherapeuticsMD, Inc. TXMD · Entity 7541 | GrantRestricted Stock Units · Derivative | 96,864 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001387131-20-005817 · ownership.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,864 Underlying: Common Stock · 96,864 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 20:19 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | GrantRestricted Stock Unit · Derivative | 123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-20-005766 · doc4.xml · derivative · entry 2 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,064 Underlying: Common Stock · 123 shares Expires not disclosed F2 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F2 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 20:19 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Grant2020 Restricted Stock Units · Derivative | 173 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-20-005766 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,746 Underlying: Common Stock · 173 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · shares: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · price: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2020 Restricted Stock Units with respect to 2020 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2020 Restricted Stock Units (including any related dividend equivalent rights in the form of 2020 Restricted Stock Units) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 20:31 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Grant2020 Stock Option (Right to Buy) · Derivative | 55,555 | $0.00 Strike: $32.43 | $0.00 |
DisclosureSEC source: 0001225208-20-005037 · doc4.xml · derivative · entry 2 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,555 Underlying: Common Stock · 55,555 shares Expires 2030-03-11 Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 20:31 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Grant2020 Restricted Stock Units · Derivative | 12,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-005037 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,573 Underlying: Common Stock · 12,573 shares Expires not disclosed F1 · derivative.exercise_price: The 2020 Restricted Stock Units convert to AIG Common Stock on a 1-to-1 basis. F2 · shares: Represents the grant of 2020 Restricted Stock Units. The 2020 Restricted Stock Units vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional 2020 Restricted Stock Units. F2 · derivative.exercise_date: Represents the grant of 2020 Restricted Stock Units. The 2020 Restricted Stock Units vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional 2020 Restricted Stock Units. F2 · derivative.expiration_date: Represents the grant of 2020 Restricted Stock Units. The 2020 Restricted Stock Units vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional 2020 Restricted Stock Units. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 21:17 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | GrantRestricted Stock Unit · Derivative | 56 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-19-016112 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,941 Underlying: Common Stock · 56 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units granted on July 29, 2019 but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The remaining unvested Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 21:41 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Tax withholdingCommon Stock | 7,092 | $51.66 | $366,372.72 |
DisclosureSEC source: 0001225208-19-015231 · doc4.xml · nonDerivative · entry 2 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,233 F2 · shares: Represents shares withheld for the payment of taxes in connection with the settlement in AIG Common Stock of the Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) that vested on December 1, 2019. F3 · price: The number of shares withheld for taxes was determined based on AIG's closing share price on December 2, 2019. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 21:41 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Exercise / conversionRestricted Stock Unit · Derivative | 13,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015231 · doc4.xml · derivative · entry 3 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,885 Underlying: Common Stock · 13,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The securities convert to AIG Common Stock on a 1-to-1 basis. F1 · shares: Represents AIG Common Stock underlying Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 that vested on December 1, 2019. The remaining Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock. F1 · derivative.exercise_date: Represents AIG Common Stock underlying Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 that vested on December 1, 2019. The remaining Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock. F1 · derivative.expiration_date: Represents AIG Common Stock underlying Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 that vested on December 1, 2019. The remaining Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 21:41 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | Exercise / conversionCommon Stock | 13,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015231 · doc4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents AIG Common Stock underlying Restricted Stock Units (including dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 that vested on December 1, 2019. The remaining Restricted Stock Units (including any related dividend equivalent rights in the form of Restricted Stock Units) granted on July 29, 2019 vest fifty percent on July 29, 2020 and fifty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 21:07 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | GrantRestricted Stock Unit · Derivative | 123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-19-012925 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,210 Underlying: Common Stock · 123 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest sixty percent on December 1, 2019, twenty percent on July 29, 2020 and twenty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest sixty percent on December 1, 2019, twenty percent on July 29, 2020 and twenty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest sixty percent on December 1, 2019, twenty percent on July 29, 2020 and twenty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest sixty percent on December 1, 2019, twenty percent on July 29, 2020 and twenty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded but not yet vested under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest sixty percent on December 1, 2019, twenty percent on July 29, 2020 and twenty percent on July 29, 2021, each subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock on a 1-to-1 basis. Read SEC document |
| July 29, 2019 Filed Jul 30, 2019 20:20 UTC | AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083 | GrantRestricted Stock Unit · Derivative | 22,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-010642 · doc4.xml · derivative · entry 1 Ling Karen · CIK 0001597450 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,087 Underlying: Common Stock · 22,087 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units convert to AIG Common Stock on a 1-to-1 basis. F2 · shares: Represents the grant of Restricted Stock Units. The Restricted Stock Units vest 60% in December 2019 and 20% in each of July 2020 and July 2021, subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional Restricted Stock Units. F2 · derivative.exercise_date: Represents the grant of Restricted Stock Units. The Restricted Stock Units vest 60% in December 2019 and 20% in each of July 2020 and July 2021, subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional Restricted Stock Units. F2 · derivative.expiration_date: Represents the grant of Restricted Stock Units. The Restricted Stock Units vest 60% in December 2019 and 20% in each of July 2020 and July 2021, subject to the reporting person's continued employment through the applicable vesting dates, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.